L. Michael Prisant

1.3k total citations
35 papers, 951 citations indexed

About

L. Michael Prisant is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, L. Michael Prisant has authored 35 papers receiving a total of 951 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Cardiology and Cardiovascular Medicine, 8 papers in Surgery and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in L. Michael Prisant's work include Blood Pressure and Hypertension Studies (20 papers), Cardiovascular Function and Risk Factors (6 papers) and Hemodynamic Monitoring and Therapy (5 papers). L. Michael Prisant is often cited by papers focused on Blood Pressure and Hypertension Studies (20 papers), Cardiovascular Function and Risk Factors (6 papers) and Hemodynamic Monitoring and Therapy (5 papers). L. Michael Prisant collaborates with scholars based in United States, Australia and Spain. L. Michael Prisant's co-authors include Amit Berson, Sheldon G. Sheps, William B. White, M. J. Jamieson, Edward J. Roccella, Albert A. Carr, Martin J. Frank, Thomas W. von Dohlen, Laurence O. Watkins and A A Carr and has published in prestigious journals such as Hypertension, European Heart Journal and The American Journal of Cardiology.

In The Last Decade

L. Michael Prisant

35 papers receiving 899 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Michael Prisant United States 18 762 258 125 109 96 35 951
Stanley H. Taylor United Kingdom 19 686 0.9× 166 0.6× 94 0.8× 76 0.7× 46 0.5× 61 902
Antone F. Salel United States 18 648 0.9× 324 1.3× 318 2.5× 124 1.1× 112 1.2× 54 1.1k
Giulio Zuanetti Italy 15 1.1k 1.4× 149 0.6× 126 1.0× 186 1.7× 119 1.2× 33 1.2k
D Magometschnigg Austria 15 708 0.9× 196 0.8× 51 0.4× 167 1.5× 49 0.5× 65 1.0k
Shafiuddin Ahmed United States 16 731 1.0× 126 0.5× 98 0.8× 48 0.4× 81 0.8× 28 1.2k
Chikao Ibuki Japan 17 537 0.7× 169 0.7× 130 1.0× 63 0.6× 108 1.1× 41 827
Hillel S. Ribner United States 14 741 1.0× 217 0.8× 54 0.4× 77 0.7× 54 0.6× 25 1.0k
Myron H. Luria Israel 21 1.0k 1.3× 522 2.0× 225 1.8× 130 1.2× 170 1.8× 44 1.4k
Min‐Seok Kim South Korea 18 772 1.0× 204 0.8× 63 0.5× 114 1.0× 70 0.7× 67 1.1k
J. I. M. Drayer United States 16 781 1.0× 158 0.6× 124 1.0× 249 2.3× 35 0.4× 32 1.1k

Countries citing papers authored by L. Michael Prisant

Since Specialization
Citations

This map shows the geographic impact of L. Michael Prisant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Michael Prisant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Michael Prisant more than expected).

Fields of papers citing papers by L. Michael Prisant

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Michael Prisant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Michael Prisant. The network helps show where L. Michael Prisant may publish in the future.

Co-authorship network of co-authors of L. Michael Prisant

This figure shows the co-authorship network connecting the top 25 collaborators of L. Michael Prisant. A scholar is included among the top collaborators of L. Michael Prisant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Michael Prisant. L. Michael Prisant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Friedman, Bruce A., et al.. (2008). Assessment of the validation of blood pressure monitors: a statistical reappraisal. Blood Pressure Monitoring. 13(4). 187–191. 23 indexed citations
2.
Prisant, L. Michael. (2005). Hypertension in the Elderly. Humana Press eBooks. 3 indexed citations
3.
Fall, Pamela J. & L. Michael Prisant. (2005). Polycystic Kidney Disease. Journal of Clinical Hypertension. 7(10). 617–625. 20 indexed citations
4.
Prisant, L. Michael, et al.. (2003). Scleroderma Renal Crisis. Journal of Clinical Hypertension. 5(2). 168–176. 2 indexed citations
5.
Prisant, L. Michael, Henry Krum, Barbara Roniker, et al.. (2003). Can Renin Status Predict the Antihypertensive Efficacy of Eplerenone Add‐On Therapy?. The Journal of Clinical Pharmacology. 43(11). 1203–1210. 23 indexed citations
6.
Prisant, L. Michael. (2002). Transdermal Clonidine Skin Reactions. Journal of Clinical Hypertension. 4(2). 136–138. 7 indexed citations
7.
Prisant, L. Michael. (2001). Verapamil Revisited. PubMed. 3(1). 55–62. 36 indexed citations
8.
Prisant, L. Michael, Peter B. Bottini, & A A Carr. (1996). Ambulatory Blood Pressure Monitoring: Methodologic Issues. American Journal of Nephrology. 16(3). 190–201. 14 indexed citations
9.
Prisant, L. Michael & George A. Mensah. (1996). Use of β ‐ Adrenergic Receptor Blockers in Blacks. The Journal of Clinical Pharmacology. 36(10). 867–873. 22 indexed citations
10.
Prisant, L. Michael, Vasilios Papademetriou, Michael A. Weber, et al.. (1995). Low-dose drug combination therapy: An alternative first-line approach to hypertension treatment. American Heart Journal. 130(2). 359–366. 60 indexed citations
11.
Prisant, L. Michael, Peter B. Bottini, & Albert A. Carr. (1992). Clinical Utility of Ambulatory Blood Pressure Monitoring in Target Organ Complications and Equipment Choices. The Journal of Clinical Pharmacology. 32(7). 620–626. 8 indexed citations
12.
Prisant, L. Michael, et al.. (1992). Pharmacotherapy of Unstable Angina. The Journal of Clinical Pharmacology. 32(5). 390–399. 4 indexed citations
13.
Prisant, L. Michael, et al.. (1992). A Negative Thallium (± Dipyridamole) Stress Test Excludes Significant Obstructive Epicardial Coronary Artery Disease in Hypertensive Patients. American Journal of Hypertension. 5(2). 71–75. 25 indexed citations
14.
Carr, Albert A., Peter B. Bottini, L. Michael Prisant, et al.. (1991). Once‐Daily Verapamil in the Treatment of Mild‐to‐Moderate Hypertension: A Double‐Blind Placebo‐Controlled Dose‐Ranging Study. The Journal of Clinical Pharmacology. 31(2). 144–150. 16 indexed citations
15.
Houghton, Jan L., L. Michael Prisant, Albert A. Carr, Thomas W. von Dohlen, & Martin J. Frank. (1991). Relationship of left ventricular mass to impairment of coronary vasodilator reserve in hypertensive heart disease. American Heart Journal. 121(4). 1107–1112. 19 indexed citations
16.
Carr, Albert A. & L. Michael Prisant. (1990). The New Calcium Antagonist Isradipine. American Journal of Hypertension. 3(1). 8–15. 17 indexed citations
17.
Prisant, L. Michael & A A Carr. (1989). Over-the-counter drugs that may increase blood pressure. Postgraduate Medicine. 86(8). 205–208. 2 indexed citations
18.
Faulkner, Jessica, et al.. (1988). Diagnosis of Hypertension in a Family Practice Setting: A Preliminary Study of Published Protocol Versus 24-Hour Ambulatory Blood Pressure Monitoring. Southern Medical Journal. 81(12). 1499–1504. 1 indexed citations
19.
Frank, Martin J., et al.. (1983). Long-term medical management of hypertrophic cardiomyopathy: usefulness of propranolol. European Heart Journal. 4(suppl F). 155–164. 23 indexed citations
20.
Frank, Martin J., et al.. (1983). Rhythm disturbances in hypertrophic cardiomyopathies: relationship to symptoms and the effect of 'complete'   blockade. European Heart Journal. 4(suppl F). 235–243. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stanley H. Taylor Breakdown of academic impact, for papers by Antone F. Salel Breakdown of academic impact, for papers by Giulio Zuanetti Breakdown of academic impact, for papers by D Magometschnigg Breakdown of academic impact, for papers by Shafiuddin Ahmed Breakdown of academic impact, for papers by Chikao Ibuki Breakdown of academic impact, for papers by Hillel S. Ribner Breakdown of academic impact, for papers by Myron H. Luria Breakdown of academic impact, for papers by Min‐Seok Kim Breakdown of academic impact, for papers by J. I. M. Drayer
Rankless by CCL
2026